Details for 2020722936

Up to date per 01.04.2026

Actions

Title / Product Name

KRISTALLINE FORMEN VON S)-1-(4-FLUOROPHENYL)-1-(2-(4-(6-(1-METHYL-1H-PYRAZOL-4-YL)PYRROLO[2,1-F][1,2,4]TRIAZIN-4-YL)PIPERAZINYL)-PYRIMIDIN-5-YL)ETHAN-1-AMIN UND VERFAHREN ZUR HERSTELLUNG DAVON

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2020722936

EP Publication Number

3856341

E-Number

1607720

Language

PCT Number

US20027724

Publication Date

04.08.2021 A

06.09.2023 B1

Registration Date

06.09.2023

AT Publication Date

15.09.2023

Application Date

10.04.2020

Registration Number

Priorities

12.04.2019

201962833527 P

07.05.2019

201962844575 P

16.03.2020

202062990269 P

IPC

A61P 17/00 20060101AFI20201016BHEP

Maximum Duration of Protection

10.04.2040

Owner

Blueprint Medicines Corporation45 Sidney Street Cambridge, MA 02139US

Representative

No representatives present

Inventor

WAETZIG, Joshua, D.45 Sidney Street Cambridge, MA 02139US

MAR, Brenton45 Sidney Street Cambridge, MA 02139US

HEINRICH, Brian45 Sidney Street Cambridge, MA 02139US

WILKIE, Gordon45 Sidney Street Cambridge, MA 02139US

MACEACHERN, Lauren39 Oathill Crescent Dartmouth, Nova Scotia, B2Y4C3CA

Information about Fees